Literature DB >> 972142

Inhibition of phosphoribosylpyrophosphate synthesis by purine nucleosides in human erythrocytes.

G Planet, I H Fox.   

Abstract

The effects of purine nucleosides on 5-phosphoribosylpyrophosphate (PP-ribose-P) synthesis were investigated in human erythrocytes in vitro. Previous observations have shown an increase of PP-ribose-P formation with nucleoside when inorganic phosphate (Pi) exceeded 20 mM. In contrast, when external Pi varied from 0 to 25 mM adenosine, inosine, guanosine, or 6-methylmercaptopurine riboside 1.25 mM decreased intracellular PP-ribose-P. The mechanism of this nucleoside effect on P-ribose-P concentration was investigated. Decreased synthesis rather than increased utilization accounted for the nucleoside effect. A decrease of erythrocyte Pi from the control values of 0.5 to 2.4 mM accompanied the nucleoside-related diminution of PP-ribose-P synthesis. This reduction of Pi was capable of decreasing the activity of PP-ribose-P synthetase which is known to be sensitive to small changes of Pi. The decrease of erythrocyte Pi levels was caused both by those nucleosides which were eventually degraded via purine nucleoside phosphorylase (adenosine, inosine, and guanosine) and by those nucleosides which were substantially phosphorylated initially by adenosine kinase (methylmercaptopurine riboside and adenosine with erythro-9(2-hydroxyl-3-nonyl)-adenine). Twenty-five per cent of methylmercaptopurine riboside was converted to the monophosphate derivative during the incubation. The presence of this compound, capable of inhibiting PP-ribose-P synthetase, provided evidence for a second mechanism of inhibition of PP-ribose-P synthesis by methylmercaptopurine riboside. No substantial increase of AMP, ADP, 2,3-diphosphoglycerate, or cyclic AMP nor a decrease of ribose 5-phosphate was found. These observations suggest that under physiological Pi concentrations nucleosides diminish PP-ribose-P synthesis mainly by decreasing intracellular Pi. Regulation of PP-ribose-P formation by alterations of intracellular Pi levels may be an important control mechanism and may account for a number of biological effects of nucleosides.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 972142

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Hepatic phosphoribosyl pyrophosphate concentration. Regulation by the oxidative pentose phosphate pathway and cellular energy status.

Authors:  S Kunjara; M Sochor; S A Ali; A L Greenbaum; P McLean
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

2.  Inhibition of salvage pathway enzymes by adenine arabinoside 5'-monophosphate (ara-AMP).

Authors:  H J Becher; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1983-08-01

Review 3.  Intracellular, nonreceptor-mediated signaling by adenosine: induction and prevention of neuronal apoptosis.

Authors:  A R Wakade; D A Przywara; T D Wakade
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

4.  Inosine/pyruvate/phosphate medium but not adenosine/pyruvate/phosphate medium introduces millimolar amounts of 5-phosphoribosyl 1-pyrophosphate in human erythrocytes. A 31P-n.m.r. study.

Authors:  A Petersen; B Quistorff
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

5.  Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.

Authors:  I H Fox; J Kaminska; N L Edwards; E Gelfand; K C Rich; W N Arnold
Journal:  Biochem Genet       Date:  1980-04       Impact factor: 1.890

6.  Nucleotide catabolism and nucleoside cycles in human thymocytes. Role of orthophosphate.

Authors:  J Barankiewicz; A Cohen
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

7.  Purines as 'hyper-repressors' of glucose transport. A role for phosphoribosyl diphosphate.

Authors:  R J Gay; H Amos
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

8.  Adenosine triphosphate turnover in humans. Decreased degradation during relative hyperphosphatemia.

Authors:  M A Johnson; K Tekkanat; S P Schmaltz; I H Fox
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

9.  Substrate inhibition of adenosine phosphorylation in adenosine deaminase deficiency and adenosine-mediated inhibition of PP-ribose-P dependent nucleotide synthesis in hypoxanthine phosphoribosyltransferase deficient erythrocytes.

Authors:  F F Snyder; C Dyer; J E Seegmiller; R M Goldblum; G C Mills; F C Schmalstieg
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

10.  Renal hypertrophy in experimental diabetes. The activity of the 'de novo' and salvage pathways of purine [corrected] synthesis.

Authors:  S Kunjara; S J Beardsley; A L Greenbaum
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.